One of the most common cancers in the world
US: 4th most common cancer
(after lung, prostate, and breast cancers)
2nd most common cause of cancer death
(after lung cancer)
2007: 130,000 new cases of CRC
56,500 deaths caused by CRC
18. Rectal Ca Radical excision - Left colon
mobilization
• Splenic flexure mobilization
• Sigmoid colon resected
– Quality of circulation is poor
– Functional outcomes as neo-rectum poor
• High ligation of IMA
– Allows mobilization of descending colon
• Ligation of main trunk of left colic
19.
20.
21.
22.
23. Radical excision-Total Mesorectal
Excision(TME)
• Introduced by RJ Heald in 1979
• Use of sharp dissection under vision to mobilize the rectum
rather than the conventional blunt finger dissection
• First series of 112 pts: 5yr LR 2.9% and survival 87.5%
• Local recurrence:
– Conventional surgery: 11.7 - 37.4%
– TME surgery: 1.6 - 17.8%
• Higher leaks rates reported possibly due to:
– Devascularisation of distal rectal stump
– Lower anastomosis
– Other factors: stomas, drains
24. TME - Technique
• Peritoneal incision around rectum
• Rectosigmoid reflected ant and posterior avascular plane
developed using sharp scissor or diathermy dissection under
vision
• Blobbed lipoma should be demonstrated
• Posterior dissection first, then lateral and finally anterior
dissection
• Do not ‘finger hook’ or clamp the lateral ‘ligaments’
• Partial TME to a distance 5cm distal to tumour
• Anterior dissection incorporates Denonvilliars fascia?
28. TME - Nerve injury
Preaortic sympathetics during high ligation
Sympathetics at the pelvic brim during rectal mobilization
Parasymp(nervi erigentes) and sympathetics during
posterolateral dissection
No clear lateral ligaments
Do not hook or clamp these tissues, avoid excessive traction
Higher rates exp by Japanese with extended lateral LN dissection
Anterior lateral dissection off the prostatic capsule
The most likely area of damage, reflected by higher rates of sexual
dysfunction in APR(14-51%) vs AR(9-29%)
The role of denonvilliars fascia
29. TME - Distal resection margin
• Not clear in the literature
• 5cm preop will expand to 7-8cm on
rectal mobilization
• This will shrink to 2-3cm with specimen
removal and formalin fixation
• Rare for tumour to spread beyond 1.5cm
• Rare reports of poorly diff tumours
having spread 4.5cm distally
• Recommend: 5cm ideally however 2cm
is adequate
30. Reconstruction of Neorectum
• Hand sewn sutured anastomosis
– 1982: Parks and Percy performed the coloanal sutured anastomosis
– ‘Pulled through’ colo-anal anastomosis (Turnbull & Cuthbertson)
• Stapled anastomosis
– Circular stapled technique
– Double stapler technique
• For low and colo-anal anastomosis
31. Reconstruction of Neorectum
Straight end to end
Low AR or Coloanal end-to-end anastomosis cause tenesmus, urgency and
incontinence (Anterior resection syndrome)
Colonic J Pouch
Increases volume of neorectum
5 vs 10cm pouches have smaller reservoirs but better evacuation
(Hida et al., Ds Colon Rectum 1996)
Size is critical to functional outcome, recommend 5-8 cm
Sigmoid colon should not be used
Better short term functional results and possible lower anastomotic leaks
compared to end-to-end anastomosis
Transverse Coloplasty
New technique introduced in 1999 (Z’graggen et al., Dig Surgery 1999)
Better in narrow pelvis and limited length of colon
Long incision closed transversely
Randomized trial underway comparing to J-pouch
34. Abdominoperineal Resection
• Described by Sir Ernest Miles 1908
• 1-2 surgeons
• TME rectal dissection
• Anus sutured closed
• Wide perineal dissection, starting from posterior to lateral then anterior
• Anterior dissection can proceed cranio-caudal or vice versa
• SB exclusion - omentum or absorbable mesh
• Drain the pelvic space
• Reduced rates of APR
– Coloanal anastomosis
– Acceptance of smaller margins
– Downsizing by chemoradiotherapy
45. History
• 1982 Semm performed first
Laparoscopic Appendicectomy
• 1987 Mouret performed first
Laparoscopic Cholecystectomy
• 1992 First UK Laparoscopic Training
centres established
47. Rewards of Minimally Invasive
Techniques
Operative Time
Cost
Benefits of
New
Techniques
Risk/Effects
Of Anesthesia,
Trauma, Etc.
48. Background
Laparoscopic colectomy 1st attempted in early 90’s
Slow to gain acceptance unlike rapid take-up of lap
cholecystectomy
Reasons for this include:
› Steep learning curve
› Cost
› Time
› Concern for oncological soundness
› Possible port site metastases
49. Preoperative Considerations
• Site (Right and sigmoid easier)
• Tumor size/invasion
• Obesity
• Previous surgery
• Almost always get a pre-op CT (cancer)
• Must talk with patient about need for
conversion to open
• Must be able to find tumor/polyp (tattoo!,
0.5cc India ink in 3-4 sites)
51. Preoperative Considerations
Continued
• Can also locate with BE
• Having to do intraoperative colonoscopy is a
flail
– CO2 colonoscopy may be better
• Bowel Preparation
– Utility is debatable, but with laparoscopy it makes
bowel easier to handle
52. Conversion to Open
• 10-25%
– Obesity
– Prior surgery
– Acute inflammation
• Fistula – 50% conversion
– Tumor bulk
• Not a failure
• Early conversion preserves good outcomes
(Wolff, 2007)
53. What difference does it make?
Laparoscopic Colectomy
•It helps you get a job
•Patients like it (thanks to the internet)
•Referring doctors like it
•But what difference does it really make
54. Outcomes
• Ileus – average 1-2 days shorter with
laparoscopy
• Less need for narcotics
• Quicker return of pulmonary function
• Length of stay ~1 day less
• May be influenced by biased expectations
– Who cares?
(Wolff, 2007)
55. Outcomes – Page 2
• Return to work and quality of life
– No statistical change
– Anecdotally improved
• Cost
– Equipment costs and OR time are greater
– May be balanced or outpaced by shorter hospital
stay
• Time – Average 30-60 minutes longer
(Wolff, 2007)
56. Port-Site Metastasis
• Initial concern greatly slowed development of
laparoscopic colectomy
• Not born out in major trials
57. Port site recurrence
• 1-21% incidence
• 3 of 14 patients
• ASCRS registry 1.1%
• Incidence in open wounds = 1%
• Not a problem
62. COST Trial
Clinical Outcomes of Surgical Therapy Study Group
• 872 patients with colonic adenocarcinoma
• Recurrence
– 16% lap
– 18% open
• Survival
– 86% lap
– 85% open
• Post-operative stay
– 5 days lap
– 6 days open
(COST Study, 2004)
63. COST Trial
Clinical Outcomes of Surgical Therapy Study Group
• 5 year data published October 2007
• Disease-free 5 year survival
– 68.4% Open
– 69.2% Laparoscopic
• Overall survival
– 74.6% Open
– 76.4% Laparoscopic
• Recurrence
– 21.8% Open
– 19.4% Laparoscopic
(COST Study, 2007)
64. COLOR Trial
COlon cancer Laparoscopic or Open Resection
• 1248 patients
• 17% conversion to open
• BMI>30 excluded (because started in 1997)
• Pathologic criteria no different
• Time to GI recovery, 1st BM, hospital stay all
one day less
• Complications were equivalent
(COLOR Trial, 2005)
65. MRC CLASSICC
Medical Research Council trial of
Conventional versus Laparoscopic-ASsisted
Surgery In Colorectal Cancer
• 794 patients
• Pathologic specimens, complications were
similar
• Time to 1st BM 1 day shorter
• Time to diet and discharge similar between
groups
(Guillou et al, 2005)
68. Long – Term Results in Colon Cancer
Lai JH, et al. Br Med Bull 2012
69. Hand Assisted Laparoscopy vs.
“Pure” Laparoscopy
• May reduce learning curve
• May be used “up front” or as a “pseudo-conversion”
• Need to make an incision large enough for the
specimen anyway
• Outcomes similar to laparoscopy, with operative
times usually shorter
76. Hand-assist vs. Laparoscopy
Marcello et al
• 95 patients - left or total colectomy
• Randomized to HA vs LAP
• Left colectomy
– 175 minutes HA, 208 LAP (p=0.021)
– Flatus 2.5 vs 3 days (p=0.64)
– Length of stay 5 vs 4 days (p=0.55)
• Total colectomy
– 127 vs 184 minutes (p=0.015)
(Marcello et al, 2008)
77. In a comparison of “pure”
laparoscopy and HALS, what does
no significant difference mean?
It means that if you can do it more easily
with one hand in, why not do it?
118. TME - Gold Standard
• Sharp dissection between the parietal and
visceral layers of the endopelvic fascia
• Complete excision of rectum & draining
lymphatics with intact visceral envelope
• Preservation of pelvic autonomics
• Low local recurrence rates (4% @ 10yrs)
Heald 1986
119. Potential Advantages of Lap TME
• Less blood loss
• Faster recovery
• Earlier return of gut function
• Lower morbidity
• Magnified view allows precise dissection
(pelvic autonomics)
120. Potential Advantages of Lap TME
• Reduced pain
• Improved cosmesis
• Decreased adhesions
• Decreased wound infection rate
• Reduced immune effect of surgery
121. Potential Disadvantages
• Steep learning curve
• Longer operating times (+30% to 50%)
• Cost
– Instruments / equipment
• Port-site recurrence?
• Oncological soundness compared with open
TME?
122. Potential Disadvantages
• Practical and technical limitations
– Crowding of instruments in the pelvis
– Plume can obscure vision
– Retraction of the rectum can be very difficult
– Division of the rectum can be difficult
– Identification of tumour site can be difficult
– Pneumoperitoneum
• Gas embolism / decreased venous return
123. Techniques
Purely Laparoscopic
› Specimen extraction through natural orifice (ie anus)
› Hand-sewn colo-anal anastomosis
› No abdominal incision apart from port sites
Laparoscopically Assisted
› Small incision for specimen retrieval
Hybrid
› Incision to allow rectal dissection, vessel ligation or
anastomosis to be performed in an open fashion
Hand-assisted Laparoscopy
› Combination of both open and laparoscopic techniques through
a hand port
124. New Technologies
• Optics / image Processing
• Energy devices (e.g. harmonic scalpel, bipolar
energy)
• New staplers
• Wound protectors / retractors
• Hand assist devices
• Robotics?
134. Technique:
General principles
• Pre-operative assessment
– Can / should it be done laparoscopically?
• Medial to Lateral dissection
• High vascular division
• Full mobilization of splenic flexure
• Rectal dissection / division / anastomosis
146. Should We Go There?
Evidence is mainly from comparative
non randomised trials
Many with small numbers & short follow-up
Two randomised trials in the literature looking
at lap TME (restorative)
› (Zhou 2004)
› MRC CLASICC (Guillou 2005)
One RCT on Lap APR
› (Araujo 2003)
147. Laparoscopy: Rectal Cancer
Open Laparoscopic
Patients 89 82
Mean age (years) 45 44
Dukes’ Stage
A
B
C
D
6
8
68
7
5
10
63
4
Prospective, Randomized, Controlled – Short-term outcome
of TME with anal sphincter preservation (ASP)
Zhou, Surg Endosc 2004
148. Laparoscopy: Rectal Cancer
Results of Surgery
Open
(n=89)
Laparoscopic
(n=82)
Distance of Tumor from Dentate (cm)
1.5-4cm
4.1-7cm
56
33
48
34
Distal Margin 1.5-3.5 1.5-4.0
Sphincter preservation 100% 100%
Anastomotic height
Low anterior (>2cm from dentate)
Ultralow anterior (<2cm from dentate)
Coloanal (at or below dentate)
35
27
27
30
27
25
Diverting ileostomy 0 0
Zhou, Surg Endosc 2004
149. Laparoscopy: Rectal Cancer
Open Laparoscopic P
value
Operative time (min) 106 120 NS
Blood loss (ml) 92 20 0.02
Parenteral analgesics (days) 4.1 3.9 NS
Solid intake (days) 4.5 4.3 NS
Hospitalization (days) 13.3 8.1 0.001
Morbidity
Anastomotic leak
12.4%
3
6.1%
1
0.016
Mortality 0 0 NS
Follow-up 1-16 months
Port site mets NA 2
Pelvic recurrence 3 0
Zhou, Surg Endosc 2004
150. MRC CLASICC:
Short term end-points of conventional vs laparoscopic-
assisted surgery in patients with rectal cancer
• Guillou et al (UK)
• Multicentre RCT
• Colon & rectal cancer
• All surgeons had performed at least 20 laparoscopic
resections
• 794 patients randomized 2:1 for laparoscopic : open
surgery
• 381 patients with rectal cancer (253:128)
Lancet 2005 365:1718-26
151. MRC CLASSIC:
Results
• Conversion 34% (overall fall in conversion rate during the
trial)
• Mortality - all patients (colon and rectal)
– Intention to treat
• Open 5% Lap 4%
– Actual treatment
• Open 5% Lap 1% Conversion 9%
Lancet 2005 365:1718-26
152. MRC CLASSIC:
Results
• Complications – rectal cancer
– Intention to treat
• Open 37% Lap 40%
– Actual treatment
• Open 37% Lap 32% Conversion 59% (p=0.002)
153. MRC CLASSIC:
Results
Open Lap Conv
• Anaesthetic time* 135 180 180 mins
• 1st BM 6 5 6 days
• Normal diet 7 6 7 days
• LOS 13 10 13 days
*Rectal and colonic resection
154. MRC CLASSIC:
Results
• Cost – intention to treat (mean)
Open Lap
• Theatre £ 1448 £ 1816
• Hospital £ 3713 £ 3359
• Others £ 2659 £ 3085
• Total £ 7820 £ 8260
Br J Cancer 2006 95:6-12
155. MRC CLASSIC:
Results
• Quality of Life
– no difference at 2 or 3 months
• Good quality pathological specimens were
received in both groups
– (nodes and length to vascular tie)
• Positive CRM rate (anterior resections)
– Laparoscopic 12% (16/129)
– Open 6% (4/64)
156. MRC CLASSIC:
Conclusions
• CLASSIC group suggest that laparoscopic anterior resection is
not justified as a routine approach due to concerns over:
– Increased positive CRM rate
– High morbidity with conversion
• Learning curve underestimated at the 20 cases used in the trial
157. Cochrane Review:
Lap vs open TME for rectal cancer
• Breukink et al (2006)
• 48 studies, 4244 patients
• Poor study methodologies, only 3 RCT’s
• No strong conclusions possible
158. Cochrane Review:
Results
• 5-year disease free survival
– No apparent difference
• Local Recurrence
– Most studies found no significant difference
– Overall <10% (variable follow up)
– Higher for APR (0% - 25%)
– 0% to 6% for sphincter-saving lap TME
– Comparable to open situation (Heald showed 33%
LR after APR)
159. Cochrane Review:
Results
• Perioperative mortality
– No significant difference
• Morbidity
– No apparent difference
– Trend towards lower complications in lap groups
• Anastomotic leak
– No difference
160. Cochrane Review:
Results
• Blood loss
– Reduced with lap TME
• Operative Time
– Significantly longer with lap TME
• Conversion Rate
– Highly variable (0 to 33%)
– Surgeon experience crucial
• Surgical margins
– No difference
161. Cochrane Review:
Results
• Lymph node harvest
– No difference
• Postoperative recovery
– Improved with lap TME
• Quality of life
– Insufficient data
162. Cochrane Review:
Results
• Cost
– Probably increased for lap TME
– Poor data
• Immune response to surgery
– Appears reduced with lap TME
163. Cochrane Review:
Conclusions
• No firm conclusions
• Laparoscopic TME appears to have short term
benefits
• Long term oncological safety requires further
randomized trials
164. Specific Issues
• Port-site hernia
– Rare at 0.3%
– Attention to port site closure
• Port site metastases
– First reported 1993
– Rare at 0.1% overall
– Comparable to wound recurrence in open surgery
165. Specific Issues
• Bladder and sexual function
– Quah (Singapore)
• 80 patients randomised to open or laparoscopic assisted
resection
• Of sexually active males 46% (7/15) decreased function in
laparoscopic group vs 6% (1/15) open
– CLASICC
• Erectile dysfunction in 41% of laparoscopic vs 23% open
(NS)
Br J Surg 2002: 89:1551–6
Br J Surg 2005: 92:1124-32
166. Laparoscopy: Total Mesorectal Excision
(TME) case control study
Breukink, Int J Colorectal Dis 2005
VARIABLE/GROUP LAPAROSCOPIC OPEN P value
OPERATIVE TIME(min) 200 180 0.06
BLOOD LOSS(ml) 250 1000 <0.001
>1000 ml FLUID INTAKE 3 6 0.002
SOLID DIET (days) 4 7 0.046
HOSPITALIZATION
(days)
12 19 0.007
MORBIDITY 37% 51% N/A
ANASTOMOTIC LEAK
(n)
2 2 N/A
MORTALITY(n) 0 1 N/A
167. Laparoscopy: Total Mesorectal Excision
(TME) case control study
VARIABLE/GROUP LAPAROSCOPIC OPEN
CIRCUMFERENTIAL
MARGIN(mm)
3 (2-31) 5 (2-31)
DISTAL MARGIN mm 35 (10-100) 10 (1-30)
NUMBER OF NODES 8 (1-25) 8 (2-20)
FOLLOW UP (months) 14 (2-31) 19 (2-31)
LOCAL RECURRENCE 0 0
DISTANT METASTASIS 5 5
Breukink, Int J Colorectal Dis 2005
168. N Conversion
OR
Time
(mins)
Anastomotic
Technique
Goh, 97 OLAR
LLAR
20
20
-
0%
73
90
Partial TME with double
staple
Leung, 97 OLAR
LLAR
50
50
-
16%
150
196
Partial TME with double
staple
Schwander, 99 OLA/pr
LLA/pr
32
32
-
NS
209
281
LAR 19 Lap 19 Open,
APR 13 Lap 13 Open
Hartley, 01 OLA/pr
LLA/pr
22
42
-
50%
125
180
LAR, APR, Hartmann
Anthuber, 03 OLA/pr
LLA/pr
334
101
-
11%
219
218
TME with colonic J if
<6cm
Breukink, 05 LAR
APR
10
31
NS 195
225
Double stapled
anastomosis
Laparoscopy: Rectal Cancer
Case controlled series for LAR
172. Laparoscopic vs. Open Surgery for
Extraperitoneal Rectal Cancer
• 191 consecutive patients
• 98 patients underwent lap resection
• 93 patients underwent open resection
Morino M, Surg Endosc 2005
173. Laparoscopic vs. Open Surgery
for Extraperitoneal Rectal Cancer
Laparoscopic
n = 98
Open
n = 93
P
Mean follow up (months) 46.3 49.7 NS
Conversion rate (%) 18.4
Mobilization (days) 1.7 3.3 < 0.001
Flatus (days) 2.6 3.9 < 0.001
Stool (days) 3.8 4.7 < 0.01
Oral intake (days) 3.4 4.8 < 0.001
Hospital stay (days) 11.4 13.0 NS
Morino M, Surg Endosc 2005
174. Laparoscopic vs. Open Surgery
for Extraperitoneal Rectal Cancer
Laparoscopic
n = 98
Open
n = 93
P
Morbidity (%) 24.4 23.6 NS
Mortality (%) 1.0 2.2 NS
Anastomotic leakage (%) 13.5 5.1 NS
Reoperation (%) 6.1 3.2 NS
Local recurrence (%) 3.2 12.6 < 0.05
Cumulative 5-year survival rate
(%)
80.0 68.9 NS
Disease-free 5-year survival rate
(%)
65.4 58.9 NS
Morino M, Surg Endosc 2005
175. Morino M, Surg Endosc 2005
Laparoscopic vs. Open Surgery
for Extraperitoneal Rectal Cancer
Conclusion
Laparoscopic resection for low and midrectal
cancer is characterized by faster recovery and
similar overall morbidity with no adverse
oncologic effect
176. Long – Term Results in Rectal Cancer
Lai JH, et al. Br Med Bull 2012
177. Conclusions
Laparoscopic TME is technically challenging
In experienced hands, lap TME can be performed safely
and confers short term post-operative benefits in terms of
recovery
Cost and quality of life data are lacking
Long term oncological outcomes are unknown, but
should be theoretically no worse if TME principles are
followed
The 3 and 5-year results from the CLASSIC trial suggest
oncological safety.
180. NICE guidelines laparoscopic
colorectal cancer - August 2006
• Laparoscopic surgery is recommended as an
alternative to open surgery for colorectal
cancer…..
• The surgeon has been trained in laparoscopic
surgery for colorectal cancer and performs the
operation often enough to keep his skills up to
date